Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 11%
Buy 22%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT is expected to experience strong internal and external growth, due to its strong portfolio of skilled nursing and senior housing facilities, as well as its high projected internal growth and ample investment opportunities. The recent re-tenanting, rent resets, and lease amendments are seen as positive signs of the company's ability to capitalize on its growth potential. However, there are some risks to consider, such as potential difficulties obtaining capital and the highly competitive nature of the industry. Additionally, any changes to reimbursement rates from governmental and third-party payers could also impact the company's ability to generate income. Overall, the current outlook for Sabra Health Care REIT is positive, with potential for continued growth and profitability.

Bears say

Sabra Health Care REIT is a healthcare facility real estate investment trust that recently incurred a significant loss on debt extinguishment. This dilution, combined with lower projected FFOps growth and a currently high valuation, results in a negative outlook for the stock. The company has a concentrated portfolio, with a high percentage of its assets in skilled nursing and behavioral health facilities, which are facing weakened fundamentals.

SBRA has been analyzed by 9 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 22% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 9 analysts, SBRA has a Hold consensus rating as of Aug 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.